PYODERMA GANGRENOSUM TREATED WITH CLOFAZIMINE - REPORT OF 3 CASES

被引：28

作者：

KARK, EC

DAVIS, BR

POMERANZ, JR

机构：

[1] CLEVELAND METROPOLITAN GEN HOSP, DEPT MED, DIV DERMATOL, CLEVELAND, OH 44109 USA

[2] CASE WESTERN RESERVE UNIV, SCH MED, CLEVELAND, OH 44106 USA

来源：

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 1981年 / 4卷 / 02期

关键词：

D O I：

10.1016/S0190-9622(81)70018-5

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

引用

页码：152 / 159

页数：8

共 12 条

[1]

DECHERD JW, 1974, CUTIS, V14, P208

[2]

ELLIS BPB, 1976, S AFR MED J, V40, P759

[3]

GRUSS JS, 1978, CAN MED ASSOC J, V118, P1237

[4] CLOFAZIMINE THERAPY OF LEPROMATOUS LEPROSY CAUSED BY DAPSONE-RESISTANT MYCOBACTERIUM-LEPRAE [J].

LEVY, L ;

FASAL, P ;

SHEPARD, CC .

AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 1972, 21 (03) :315-&

[5] SPLENIC INFARCTION AND TISSUE ACCUMULATION OF CRYSTALS ASSOCIATED WITH THE USE OF CLOFAZIMINE (LAMPRENE - B663) IN THE TREATMENT OF PYODERMA GANGRENOSUM [J].

MCDOUGALL, AC ;

HORSFALL, WR ;

HEDE, JE ;

CHAPLIN, AJ .

BRITISH JOURNAL OF DERMATOLOGY, 1980, 102 (02) :227-230

[6]

MICHAELSSON G, 1976, ARCH DERMATOL, V112, P334

[7]

MOLIN L, 1975, ACTA DERM-VENEREOL, V55, P151

[8]

OLSON K, 1971, ACTA DERM-VENEREOL, V51, P233

[9]

PEACHEY RDG, 1974, BRIT J DERMATOL, V90, P106

[10] CLOFAZIMINE IN THE TREATMENT OF PYODERMA GANGRENOSUM [J].

THOMSEN, K ;

ROTHENBORG, HW .

ARCHIVES OF DERMATOLOGY, 1979, 115 (07) :851-852

← 1 2 →